Essential Partners’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$360K Sell
6,620
-5,907
-47% -$288K 0.17% 121
2026
Q1
$537K Sell
12,527
-11,819
-49% -$508K 0.18% 137
2025
Q4
$1.07M Buy
24,346
+6,662
+38% +$276K 0.33% 80
2025
Q3
$730K Buy
17,684
+1,565
+10% +$62.9K 0.24% 113
2025
Q2
$710K Buy
+16,119
New +$644K 0.28% 104

Other funds holding EXEL

Essential Partners's EXEL Position: Q2 2026 in Review

Essential Partners reduced its Exelixis (EXEL) stake by 47% in Q2 2026, selling an estimated $288K and leaving 6,620 shares worth $360K. The position accounts for 0.17% of the portfolio, ranked #121.

Essential Partners first reported a position in EXEL in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.07M in Q4 2025. 756 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Essential Partners held 6,620 shares of Exelixis worth $360K as of Q2 2026.
  • Essential Partners sold 5,907 Exelixis shares in Q2 2026, an estimated $288K.
  • Exelixis made up 0.17% of Essential Partners's portfolio in Q2 2026, its #121 holding.
  • Essential Partners first reported a position in Exelixis in Q2 2025 and has held it in 5 quarters since.
  • Essential Partners's Exelixis position peaked at $1.07M in Q4 2025.
  • 756 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.